Navigation Links
Sigma-Aldrich Corporation's Sigma Life Science Business to Distribute Worldwide Olink Bioscience's Protein Interaction Analysis Technology
Date:2/12/2013

d there from. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of management regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that Olink's technology or related Sigma technologies and services will assist the Company to achieve any particular levels of revenue in the future. In particular, management's expectations regarding products associated with Olink's technology or related Sigma technologies and services could be affected by, among other things, unexpected regulatory actions or delays or government regulation generally; the Company's ability to obtain or maintain patent or other proprietary intellectual property protection; competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Company's assets and liabilities as recorded in its consolidated balance sheet, and other risks and factors referred to in Sigma-Aldrich's current Form 10-K on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Sigma-Aldrich is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

About Sigma-Aldrich: Sigma-Aldrich Corporation is a leading Life Science and High Technology company whose biochemical, organic chemical products, kits and services are used in scientific research, includin
'/>"/>

SOURCE Sigma-Aldrich Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Sigma-Aldrich Reports Record Full Year 2012 Results. Reports Q4 2012 Diluted EPS Of $0.96. Q4 2012 Sales Increased 7%. Full Year 2012 Adjusted Diluted EPS Was $3.85. Expects Full Year 2013 Adjusted Diluted EPS To Increase To $4.10 - $4.20.
2. Sigma-Aldrich Aligns Into Three New Market-Focused Business Units
3. Sigma-Aldrich (NASDAQ: SIAL) Declares $0.20 Quarterly Dividend
4. Sigma-Aldrich Enhances Customer Focus in China - Unveils Dynamic New Website and Expands Product Offering Through Vetec Brand
5. Sigma-Aldrich Corporation To Present At Upcoming Investor Conferences
6. Sigma-Aldrich Accelerates Analytical Research and Extends Benefits of Fused-Core Particle Technology to All HPLC Users with the Launch of New Ascentis Express 5 Micron Particle by Supelco
7. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
8. Henry Schein Ranks #303 In 2012 FORTUNE 500® Ranking Of Americas Largest Corporations
9. NeuroSigma Invited to Present an Overview of eTNS for the Treatment of Epilepsy and Depression at The Royal Society of Medicine in London
10. NeuroSigma Awarded Fast Track SBIR Grant by the NIH for Development of Implantable sTNS System for Drug Resistant Epilepsy
11. NeuroSigma Announces Receipt of Notice of Allowance of U.S. Patent Application Related to External Trigeminal Nerve Stimulation (eTNS) for the Treatment of Neuropsychiatric Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... MADISON HEIGHTS, Mich. , March 4, 2015 /PRNewswire/ ... national provider of infusion pumps and related services for ... issue fourth quarter and full year 2014 financial results ... The Company will also conduct a conference ... 4:30 p.m. Eastern Time to discuss fourth quarter and ...
(Date:3/4/2015)... WASHINGTON , March 4, 2015  Mail-service ... consumers, employers and government health plans ... research released by the Pharmaceutical Care Management Association ... specialty drugs offers one of the easiest ways ... CEO Mark Merritt . "Policymakers should resist ...
(Date:3/4/2015)... , March 4, 2015   Mayo Clinic ... agreement to develop the next generation of wearable biosensors ... are hoping that this technology will be game-changer. These ... diabetes," says James Levine, M.D., Ph.D. , a ... are accurate, inexpensive, and can be integrated into the ...
Breaking Medicine Technology:PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Illinois Employers, Consumers and Public Programs by $11.8 Billion 2Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 2Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 3
... Accuray Incorporated (Nasdaq: ARAY ), a global ... accepted abstracts highlighting the use of the CyberKnife Robotic Radiosurgery ... 52nd Annual Meeting of the American Society for Radiation Oncology ... Presentations related to CyberKnife radiosurgery cover a ...
... HSIC ), the largest provider of healthcare products ... for the quarter ended September 25, 2010. Net ... an increase of 14.1% compared with the third quarter of ... a decline of 2.3% related to foreign currency exchange.  Internal ...
Cached Medicine Technology:Accuray's CyberKnife VSI System Featured at 2010 American Society for Radiation Oncology (ASTRO) Annual Meeting 2Accuray's CyberKnife VSI System Featured at 2010 American Society for Radiation Oncology (ASTRO) Annual Meeting 3Accuray's CyberKnife VSI System Featured at 2010 American Society for Radiation Oncology (ASTRO) Annual Meeting 4Henry Schein Reports Record Third Quarter Results 2Henry Schein Reports Record Third Quarter Results 3Henry Schein Reports Record Third Quarter Results 4Henry Schein Reports Record Third Quarter Results 5Henry Schein Reports Record Third Quarter Results 6Henry Schein Reports Record Third Quarter Results 7Henry Schein Reports Record Third Quarter Results 8Henry Schein Reports Record Third Quarter Results 9Henry Schein Reports Record Third Quarter Results 10Henry Schein Reports Record Third Quarter Results 11
(Date:3/4/2015)... (PRWEB) March 04, 2015 Dr. Christopher ... NuMale Medical Center today lamented the FDA’s recent ... therapy (TRT). He argued that FDA’s conclusions are ... harm men who suffer from testosterone deficiency. , “The ... equivocation” on testosterone replacement therapy,” said Dr. Asandra. “There ...
(Date:3/4/2015)... Austria (PRWEB) March 04, 2015 ... reduce subjectivity in density assessment and help improve ... of numerous abstracts accepted for presentation at the ... 2015. Ten abstracts - eight posters and ... Volpara Solutions’ automated breast density and quantitative breast ...
(Date:3/4/2015)... 2015 Starting February 2015, Dr. Joseph ... procedures at their new location in Surrey. , In ... and Dr. Gabriel Chu also provide comprehensive ophthalmology services, ... named Fraser Valley Cataract and Laser (FVCL). This state ... College of Physicians and Surgeons of British Columbia. Fraser ...
(Date:3/4/2015)... Georgia (PRWEB) March 04, 2015 State ... part of the School of Public Health at Georgia ... The funds were awarded by Georgia’s Division of Family ... to support the DFCS Call Center. , The ... maltreatment by providing information and referral services that promote ...
(Date:3/4/2015)... La Farge, Wis. (PRWEB) March 04, 2015 ... a leading organic brand, today announced its cause campaign to ... has gone viral and is making a difference to Bros ... million views on Youtube and Facebook. The video was ... and was featured in Forbes, Mashable and Digiday, among other ...
Breaking Medicine News(10 mins):Health News:NuMale’s Dr. Christopher Asandra: FDA Suffering from “Premature Equivocation” on Issue of Testosterone and Risks 2Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 2Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 3Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 4Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 5Health News:King LASIK relocates to Surrey, British Columbia 2Health News:State Funds Child Abuse Helpline Housed At Georgia State 2Health News:ORGANIC VALLEY URGES PUBLIC TO SAVE THE BROs: CAMPAIGN EARNS MORE THAN 1M VIEWS ON YOUTUBE 2Health News:ORGANIC VALLEY URGES PUBLIC TO SAVE THE BROs: CAMPAIGN EARNS MORE THAN 1M VIEWS ON YOUTUBE 3
... for treatment of Human Immunodeficiency Virus type 1 ... of combination therapy in 1996//. More recently, new ... and improved safety profiles, while some previously popular ... drawbacks become better defined. Resistance testing is used ...
... Bill Ledger, of Sheffield University has developed a test, which ... woman has left//. ,The test, which is expected ... fertility is dropping off. The development has been hailed to ... give women the same control over their fertility as the ...
... of Oxford, UK has found a new theory from the ... administered world wide for children’s to prevent// from Tuberculosis infection ... with TB infection. The researchers studied the risk factors involved ... had BCG scar, as the absence of BCG scar implies ...
... teeth and gums are photosensitive says an article published ... The paper authored by a researcher at Washington University// ... is an important factor in the maintenance of oral ... to oral health," observed study author Charles F. Hildebolt, ...
... (ED) is the inability of a man to achieve or ... needs of his partner. Most men experience this at some ... not psychologically affected by it. Some men, however, experience chronic, ... ,According to a new study in the October 18 ...
... fish has been proved with evidence following the finding that ... of three to four years. The research adds to the ... sharp//. ,Previous findings have established that consumption of ... Alzheimer’s disease and stroke. Fish such as salmon and tuna ...
Cached Medicine News:Health News:Simplest therapeutic regimen found less effective against HIV 2Health News:Women can now gauge their own future fertility 2Health News:BCG vaccine for both Protection and treatment of Tuberculosis 2Health News:Sunlight For Healthy Gums And Teeth 2Health News:Erectile dysfunction: an early warning sign of clinically silent coronary artery disease? 2
... fixed pipette is ideal for ... volume. Fixed volume FInnpipettes offer ... as other Finnpipette Digital pipettes: ... blow-out (1-40ul), Soft-touch tip ejection, ...
500L...
... ergonomics, and value!, Comfortable feel ... non-slip, contoured handle , Finer control ... spring action , Completely autoclavable for ... need for recalibration , Easy-to-read precision ...
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
Medicine Products: